ClinicalTrials.gg
Enrolling by invitationNCT06812767FORTUNEUpdated Feb 6, 2025

Risk Factors at Chronic Non-communicable Diseases in People of Working Age

An observational study in Chronic Non-communicable Disease, sponsored by National Medical Research Center for Therapy and Preventive Medicine. Enrolling by invitation at 1 site in Russian Federation. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-06.

Sponsored by National Medical Research Center for Therapy and Preventive Medicine · Observational

From the registry’s dates

  • Primary completion was expected by Apr 2026, 7 months ago, but the record still lists the study as enrolling by invitation.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
2,000
Ages
18 Years and older
Sex
All
01

Study summary

Objectives: to study the clinical and demographic characteristics of working age persons, to highlight the main factors of non-communicable diseases (NCDs), to identify NCDs with physical examination, laboratory tests, electrocardiography and ultrasound imaging, to develop a corporate prevention program for the company to reduce the risk of complications of NCDs.

Research stages:

  1. Questionnaire to identify socio-demographic, behavioral, hereditary, psycho-emotional risk factors of NCDs
  2. Laboratory tests (analysis of glucose and cholesterol in the capillary blood, detection of microalbuminuria), diagnostic tests (electrocardiography, and carotid artery ultrasound)
  3. Evaluation of the results of questionnaires and surveys. Recommendations for lifestyle modification and follow-up in a local healthcare department
Read the detailed description

Currently the emphasis in preventive medicine is also on health of the working population, which is a key state policy in the Russian Federation. Health of working citizens is an important factor in the development and safety of the production sector, but it is also the key to health and well-being of all other groups - children and older generations - that is, in fact, the fundamental factor for social development. Therefore, the integration of health-saving technologies into all areas of working life, including production and work activities, is particularly important. In today's world, it is very important that everyone actively participate in the preservation the health of the individual and its high awareness. Awareness of risk factors for chronic non-communicable diseases and measures prevention throughout life is an important part of a healthy society. Monitoring the health of working citizens allows to predict the problem and take the necessary measures in a timely manner.

In the Russian Federation, medical screening is a complex system, including medical examination by physicians of several specialties and application of the necessary methods of examination to identify chronic non-communicable diseases and their risk factors at an early stage that are the main cause of disability and premature mortality in the country's population, and also to form health status groups and provide recommendations for patients. The examination is carried out once every three years and includes a set of methods of advanced examination to identify early on the most likely chronic non-communicable disease for a given age and gender. Regular checkups are the most important mass and highly effective medical technology of health savings.

The work of carrying out regular preventive examinations and check-ups is carried out by primary health care. Often the quality of such work is limited by manpower shortages, technological and logistical barriers. In modern conditions, these obstacles can be overcome by using mobile systems that include modern digital diagnostic technologies, Allow for more in-depth investigation and identification of risk factors not covered by the standard examination protocol. This will increase the coverage and detection of risk factors, which is an important component of the health saving of the working population

02

Conditions studied

  • Chronic Non-communicable Disease

Keywords

  • arterial hypertension
  • coronary heart disease
  • cerebrovascular disease
  • malignant tumors
  • chronic obstructive pulmonary disease
  • asthma
  • diabetes mellitus
  • environment
  • smoking
  • alcohol consumption
  • unbalanced diet
  • hypodynamia
  • obesity
  • overweight
  • dyslipidemia
  • hyperglycemia
  • microalbuminuria
03

In context

Noncommunicable Diseases

144 studies on the registry are indexed under Noncommunicable Diseases; 55 are open to participants now.

This study's planned enrollment of 2,000 is above the median of 1,674 across 48 observational studies indexed under Noncommunicable Diseases.

Browse Noncommunicable Diseases studies →

Lead sponsor

National Medical Research Center for Therapy and Preventive Medicine is the lead sponsor of 29 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

The study is planned to include all working citizens who meet the inclusion criteria and have come for preventive examination. In total, at least 2,000 people are planned to be included in the study. All participants will be given informed consent to participate in the clinical trial

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • employees of the company
  • persons without NCDs diagnosis and not receiving permanent medication
  • residents of the region of the Russian Federation where a factory with permanent or temporary registration is located

Exclusion criteria

Exclusion Criteria:

  • refusal to sign
  • any NCDs requiring constant medication
  • active cancer
  • pulmonary embolism
  • valve defects of the heart (except secondary mitral regurgitation)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
2,000 participants (estimated)
Patient registry
No
Biospecimen retention
None retained

Groups and cohorts

  • Persons without NCDs

    Persons without known NCDs and not using any medication on a permanent basis

    Diagnostic Test: electrocardiography · Diagnostic Test: analysis for glucose and cholesterol in the capillary blood · Diagnostic Test: detection of microalbumuria · Diagnostic Test: heart ultrasound examination · Diagnostic Test: carotid artery ultrasound examination

Interventions

  • Diagnostic testelectrocardiography

    12 standard leads

  • Diagnostic testanalysis for glucose and cholesterol in the capillary blood

    express test

  • Diagnostic testdetection of microalbumuria

    express test

  • Diagnostic testheart ultrasound examination

    Ultrasound examination with Lumify Handheld S4-1 Phased Array Ultrasound (Philips)

  • Diagnostic testcarotid artery ultrasound examination

    Ultrasound examination with Lumify Handheld L12-4 Linear Array Ultrasound (Philips)

06

What researchers measure

Primary outcomes

  1. prevalence of NCDs risk factors

    risk factors of NCDs based on survey results and diagnostic tests

    Time frame: on enrollment

  2. prevalence of NCDs

    diagnosed NCDs based on survey results, and diagnostic tests

    Time frame: on enrollment

Secondary outcomes

  1. Hospitalization

    Urgent or emergent hospitalization during the visit if indicated

    Time frame: on enrollment

07

Study locations

1 site
  • National Medical Research Center for Therapy and Preventive Medicine
    Moscow, Russian Federation
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06812767
Lead sponsor
National Medical Research Center for Therapy and Preventive Medicine
Responsible party
Sponsor
First posted
Feb 6, 2025
Start date
Apr 2025 (estimated)
Primary completion
Apr 2026 (estimated)
Completion
Apr 2026 (estimated)
Last update
Feb 6, 2025

Study contacts

Olga Dzhioeva, MD, PhD
study director · National Medical Research Center for Therapy and Preventive Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion